| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110;
Blood Transfusion Service, Finnish Red Cross, Helsinki, Finland;
Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL 35294;
§
Raahe District Hospital, Raahe, Finland; and
¶
Children’s Hospital Research Foundation, Department of Pediatrics, Ohio State Biochemistry Program, and Department of Medical Microbiology and Immunology, Ohio State University, Columbus, OH 43205
The complement protein C4, encoded by two genes (C4A and C4B) on chromosome 6p, is the most polymorphic among the MHC III gene products. We investigated the molecular basis of C4 deficiency in a Finnish woman with systemic lupus erythematosus. C4-specific mRNA was present at low concentrations in C4-deficient (C4D) patient fibroblasts, but no pro-C4 protein was detected. This defect in C4 expression was specific in that synthesis of two other complement proteins was normal. Analysis of genomic DNA showed that the proposita had both deleted and nonexpressed C4 genes. Each of her nonexpressed genes, a C4A null gene inherited from the mother, a C4A null gene, and a C4B null gene inherited from the father, all contained an identical 2-bp insertion (TC) after nucleotide 5880 in exon 29, providing the first confirmatory proof of the C4B pseudogene. This mutation has been previously found only in C4A null genes. Although the exon 29/30 junction is spliced accurately, this frameshift mutation generates a premature stop at codon 3 in exon 30. These truncated C4A and C4B gene products were confirmed through RT-PCR and sequence analysis. Among the possible genetic mechanisms that produce identical mutations in both genes, the most likely is a mutation in C4A followed by a gene conversion to generate the mutated C4B allele.
This article has been cited by other articles:
|
|
 |
|
  S. Puah, L. Lian, C. Chew, K. Chua, and S. Tan A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population Lupus, September 1, 2007; 16(9): 750 - 754. [Abstract] [PDF]
|
|
|
|
|
|
K Lhotta, R Wurzner, A R Rosenkranz, R Beer, A Rudisch, F Neumair, and G Mayer Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus Lupus, February 1, 2004; 13(2): 139 - 141. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Jaatinen, M. Lahti, O. Ruuskanen, R. Kinos, L. Truedsson, R. Lahesmaa, and M.-L. Lokki Total C4B Deficiency Due to Gene Deletion and Gene Conversion in a Patient with Severe Infections Clin. Vaccine Immunol., March 1, 2003; 10(2): 195 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Rupert, J. M. Moulds, Y. Yang, F. C. Arnett, R. W. Warren, J. D. Reveille, B. L. Myones, C. A. Blanchong, and C. Y. Yu The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes J. Immunol., August 1, 2002; 169(3): 1570 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jaatinen, M. Eholuoto, T. Laitinen, and M.-L. Lokki Characterization of a De Novo Conversion in Human Complement C4 Gene Producing a C4B5-Like Protein J. Immunol., June 1, 2002; 168(11): 5652 - 5658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Blanchong, B. Zhou, K. L. Rupert, E. K. Chung, K. N. Jones, J. F. Sotos, W. B. Zipf, R. M. Rennebohm, and C. Y. Yu Deficiencies of Human Complement Component C4A and C4B and Heterozygosity in Length Variants of RP-C4-CYP21-TNX (RCCX) Modules in Caucasians: The Load of RCCX Genetic Diversity on Major Histocompatibility Complex-associated Disease J. Exp. Med., June 19, 2000; 191(12): 2183 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, A. R. Mendoza, T. R. Welch, W. B. Zipf, and C. Y. Yu Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module). A MECHANISM FOR GENE DELETIONS AND DISEASE ASSOCIATIONS J. Biol. Chem., April 23, 1999; 274(17): 12147 - 12156. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
